Since BAFF is differentially upregulated in pulmonary fibrosis and correlative with disease severity, BAFF may represent an attractive therapeutic target, though further work examining the efficacy of pulmonary BAFF inhibition is needed. This evidence concerns the gene TNFSF13B and pulmonary fibrosis.